Salmonella enterica serotype Paratyphi B is a bacterium that can cause a range of diseases in humans, from gastroenteritis to paratyphoid fever . This serotype comprises two biotypes: sensu stricto, associated with paratyphoid fever, and Java, linked to gastroenteritis . Due to the rise of antimicrobial resistance and the absence of licensed vaccines, monitoring and tracking the transmission of Salmonella Paratyphi is crucial .
Fumarate reductase is an enzyme that functions in the anaerobic respiratory chains of many bacteria, including Salmonella . It catalyzes the reduction of fumarate to succinate, enabling the bacteria to generate energy in the absence of oxygen. The enzyme is a membrane-bound complex composed of several subunits, including FrdD .
Fumarate reductase (Frd) is an enzyme complex that catalyzes the reduction of fumarate to succinate in anaerobic respiration . In Salmonella, Frd is essential for energy production in the absence of oxygen. The Frd enzyme complex consists of four subunits, FrdA, FrdB, FrdC, and FrdD. FrdD is a membrane anchor protein that is required for the assembly and function of the fumarate reductase complex .
The frdD gene encodes the FrdD subunit of the fumarate reductase complex. The disruption of the frdD gene leads to the loss of fumarate reductase activity, impairing the ability of Salmonella to grow anaerobically .
Recombinant FrdD is produced using in vitro E. coli expression system .
A Salmonella enterica serovar Typhimurium SR-11 ΔfrdABCD mutant (fumarate reductase), deficient in the ability to run the reductive branch of the tricarboxylic acid (TCA) cycle, was fully virulent . A serovar Typhimurium SR-11 ΔfrdABCD ΔsdhCDA double mutant is avirulent in BALB/c mice and protective against subsequent infection with the virulent serovar Typhimurium SR-11 wild-type strain via the peroral route and is highly attenuated via the intraperitoneal route . Fumarate reductase can replace succinate dehydrogenase during infection to run a full TCA cycle in an SR-11 ΔsdhCDA mutant . The conversion of succinate to fumarate plays a key role in serovar Typhimurium virulence .
Dimethyl sulfoxide (DMSO) reduction is one metabolic process used to support Salmonella gut colonization . A S. Typhimurium mutant with loss of function in all three putative DMSO reductases (ΔdmsA) poorly colonizes the mammalian intestine when the microbiota is intact and when inflammation is absent . DMSO reduction enhances anaerobic growth through nonredundant contributions of two of the DMSO reductases . Furthermore, DMSO reduction influences virulence by increasing expression of the type 3 secretion system 2 and reducing expression of the type 3 secretion system 1 .
Two distinct, membrane-bound, FAD-containing enzymes catalyze the interconversion of fumarate and succinate. Fumarate reductase is utilized during anaerobic growth, while succinate dehydrogenase functions during aerobic growth. FrdD anchors the catalytic components of the fumarate reductase complex to the inner cell membrane and binds quinones.
KEGG: spq:SPAB_05471
Salmonella paratyphi B Fumarate reductase subunit D (frdD) is a 13 kDa hydrophobic protein that functions as part of the fumarate reductase complex. The protein consists of 119 amino acids with the sequence: MINPNPKRSDEPVFWGLFGAGGMWGAIIAPVIVLLVGIMLPLGLFPGDALSFERV LTFAQSFIGRVFLFLMIVLPLWCGLHRMHHAMHDLKIHVPAGKWVFYGLAAILTVVTAIGVITL . The protein is characterized by its hydrophobic nature, which facilitates its integration into the membrane. As a subunit of the fumarate reductase complex, frdD anchors the catalytic components to the membrane, enabling electron transport during anaerobic respiration in Salmonella species.
For optimal expression of recombinant Salmonella paratyphi B frdD, E. coli-based expression systems are commonly employed with specific modifications to accommodate the hydrophobic nature of the protein. The most effective systems typically utilize:
pET expression systems with T7 promoters under IPTG control, allowing for high-yield production
Codon-optimized sequences to enhance translation efficiency in the host organism
Fusion tags such as His6, GST, or MBP to facilitate purification and potentially increase solubility
Specialized E. coli strains engineered for membrane protein expression (e.g., C41(DE3) or C43(DE3))
For hydrophobic proteins like frdD, expression conditions typically require lower induction temperatures (16-25°C) and moderate inducer concentrations to prevent formation of inclusion bodies and maintain proper membrane integration.
Recombinant frdD protein should be stored in Tris-based buffer with 50% glycerol at -20°C for short-term storage or -80°C for extended preservation . To maintain protein integrity, consider these best practices:
Divide the protein into small working aliquots (20-50 μL) to avoid repeated freeze-thaw cycles
Store working aliquots at 4°C for up to one week to minimize degradation
Avoid repeated freezing and thawing, as this can significantly reduce protein activity
Include protease inhibitors in storage buffers if degradation is observed
Monitor protein stability periodically through activity assays or gel electrophoresis
For long-term archiving, lyophilization may be considered but should be validated to ensure the protein retains functionality upon reconstitution.
Verification of recombinant frdD identity and purity should employ a multi-method approach:
SDS-PAGE analysis: Should show a band at approximately 13 kDa, corresponding to the predicted molecular weight of frdD
Western blotting: Using anti-frdD antibodies or anti-tag antibodies if a fusion protein construct is used
Mass spectrometry: For precise molecular weight determination and peptide mapping
N-terminal sequencing: To confirm the correct amino acid sequence
For purity assessment, densitometry analysis of SDS-PAGE gels should indicate >90% purity for most research applications. Size exclusion chromatography can provide additional purity information and detect potential aggregation. Given the hydrophobic nature of frdD, specialized detergent-based electrophoresis methods may be required for optimal resolution.
When designing experiments for frdD mutation analysis in Salmonella paratyphi B, researchers should consider:
Mutation strategy selection:
Site-directed mutagenesis for targeted amino acid changes
Deletion mutagenesis to assess domain functionality
Random mutagenesis for functional screens
Phenotypic assessment plan:
Growth curves under aerobic vs. anaerobic conditions
Fumarate reductase activity assays
Membrane integration analysis
Controls:
Wild-type strain
Empty vector controls
Complementation controls to verify phenotype restoration
Experimental validation:
Multiple independent mutants to confirm phenotypes
Sequence verification of all constructs
Protein expression confirmation
For robust experimental design, use the Framework for Reliable Experimental Design (FRED) principles, ensuring proper planning, implementation, and analysis to establish reliable findings .
Assessing functional activity of recombinant frdD requires specialized methods due to its role as a membrane anchor subunit:
Reconstitution assays:
Incorporate purified frdD into liposomes or nanodiscs
Combine with other fumarate reductase subunits (frdA, frdB, frdC)
Measure complex formation using crosslinking or co-immunoprecipitation
Membrane insertion analysis:
Protease accessibility assays to determine topology
Fluorescence resonance energy transfer (FRET) with labeled components
Differential scanning calorimetry to assess membrane stability
Electron transport activity:
Measure electron transfer using artificial electron donors/acceptors
Monitor fumarate reduction spectrophotometrically at 300 nm
Assess proton translocation using pH-sensitive dyes
A comprehensive analysis should combine multiple approaches to distinguish between protein expression, membrane insertion, complex formation, and enzymatic activity contributions.
For effective genetic modification of frdD in Salmonella paratyphi B, consider these validated methodologies:
Homologous recombination:
Lambda Red recombinase system for precise chromosomal modifications
Integration of modified frdD variants at the native locus
Counter-selection markers (e.g., sacB) for marker-free modifications
CRISPR-Cas9 gene editing:
Design specific gRNAs targeting the frdD locus
Introduce donor templates with desired modifications
Screen transformants using PCR and sequencing
Suicide vector integration:
Vectors like pYG4 that cannot replicate in Salmonella
Selection for chromosomal integration events
Counter-selection for excision of vector backbone
Similar approaches have been successfully used for other Salmonella genes such as htrA, phoP/phoQ, and sptP in Salmonella Paratyphi A , and can be adapted for frdD modification in S. Paratyphi B.
The contribution of frdD to Salmonella paratyphi B pathogenesis is multifaceted and involves several metabolic adaptations:
Anaerobic respiration: As part of the fumarate reductase complex, frdD enables S. paratyphi B to use fumarate as a terminal electron acceptor during oxygen limitation in host tissues, particularly within macrophages and the intestinal lumen.
Metabolic adaptation: The fumarate reductase complex contributes to pathogen fitness during infection by facilitating:
Energy generation under anaerobic conditions
Utilization of alternative carbon sources
Adaptation to nutrient-limited environments within host cells
Intracellular survival: There is evidence that fumarate metabolism may contribute to resistance against host defense mechanisms, similar to what has been observed with other metabolic genes in Salmonella.
While not directly analogous to virulence factors like those in the Type III secretion system (e.g., SptP) , frdD's role in energy metabolism makes it an important contributor to S. paratyphi B survival during infection. This relationship between metabolism and virulence represents an emerging area for therapeutic intervention.
Developing effective antibodies against recombinant frdD presents several unique challenges:
Hydrophobicity: The highly hydrophobic nature of frdD (as evidenced by its amino acid sequence) can limit epitope accessibility and require specialized immunization strategies.
Conformational considerations: The native membrane-embedded conformation of frdD differs significantly from solubilized recombinant forms, potentially yielding antibodies that recognize denatured but not native protein.
Cross-reactivity concerns: High sequence conservation among fumarate reductase D subunits across bacterial species can result in antibodies with limited specificity for S. paratyphi B.
To address these challenges, researchers should consider:
Using synthetic peptides from hydrophilic regions as immunogens
Employing recombinant frdD fragments fused to carrier proteins
Developing monoclonal antibodies with stringent screening for specificity
Validating antibodies using knockout strains and Western blots with multiple controls
While traditional vaccine approaches for Salmonella have focused on O-polysaccharides, outer membrane proteins, and secretion system components , recombinant frdD offers potential alternative pathways for vaccine development:
Subunit vaccine components:
Hydrophilic epitopes of frdD could be incorporated into multi-epitope vaccines
Fusion protein constructs combining frdD peptides with immunogenic carriers
Live attenuated vaccine platforms:
Engineered S. paratyphi B strains with modified frdD expression
Metabolic attenuation through frdD mutation combined with other attenuating mutations
Novel delivery approaches:
Outer membrane vesicles (OMVs) containing frdD
Nanoparticle formulations displaying frdD epitopes
A promising strategy involves combining frdD-targeted approaches with established vaccine technologies. For example, the S. Paratyphi A vaccine approach using chromosomal integration of the viaB locus could be adapted to include modifications of frdD in S. paratyphi B, potentially creating a metabolically attenuated strain with enhanced immunogenicity.
When conducting comparative studies of fumarate reductase subunit D across Salmonella serovars, implement these systematic approaches:
Sequence analysis pipeline:
Multiple sequence alignment of frdD homologs
Phylogenetic analysis to establish evolutionary relationships
Identification of conserved versus variable regions
Prediction of functional domains and transmembrane segments
Structural comparison:
Homology modeling based on available crystal structures
Molecular dynamics simulations in membrane environments
Identification of serovar-specific structural features
Functional characterization:
Cross-complementation experiments between serovars
Enzyme kinetics comparison under standardized conditions
Membrane integration efficiency assessment
Expression pattern analysis:
Transcriptomic profiling across growth conditions
Comparison of regulation mechanisms between serovars
Protein abundance quantification using targeted proteomics
This comparative approach can reveal important insights into how metabolic adaptations contribute to the distinct host preferences and disease manifestations observed between Salmonella serovars such as S. Typhi, S. Paratyphi A, and S. Paratyphi B .
Low expression yields of recombinant frdD are common due to its hydrophobic nature. Implement these evidence-based strategies to improve production:
Expression system optimization:
Test alternative E. coli strains specialized for membrane proteins (C41/C43)
Evaluate different promoter systems (trc, ara, T5) for optimal expression level
Consider cell-free expression systems for difficult constructs
Growth condition modifications:
Reduce induction temperature to 16-20°C
Decrease inducer concentration (0.1-0.5 mM IPTG)
Supplement media with glycerol (0.5-2%) to support membrane formation
Add specific lipids that promote membrane protein integration
Construct engineering:
Add solubility-enhancing fusion partners (MBP, NusA, Trx)
Optimize codon usage for expression host
Consider expression of individual transmembrane segments
Purification approach:
Use specialized detergents (DDM, LDAO, or FC-12)
Implement on-column detergent exchange protocols
Add stabilizing agents during purification
Systematic testing of these variables using Design of Experiments (DoE) methodology can efficiently identify optimal conditions for your specific construct.
When encountering data inconsistencies in frdD functional studies, apply this systematic troubleshooting framework:
Sample preparation validation:
Verify protein integrity with fresh aliquots
Confirm protein concentration using multiple methods
Assess aggregation state using size exclusion chromatography
Assay condition standardization:
Control temperature precisely (±0.5°C)
Prepare fresh buffers and reagents
Validate pH stability throughout experiments
Minimize variability in detergent concentrations
Instrumentation verification:
Calibrate spectrophotometers/fluorimeters regularly
Perform positive and negative control reactions
Include internal standards when possible
Data analysis refinement:
Apply appropriate statistical tests
Identify and address outliers systematically
Implement blinding in analysis when feasible
Biological variability assessment:
Test multiple protein preparations
Consider batch effects in expression systems
Account for genetic background differences
Following the Framework for Reliable Experimental Design (FRED) principles can help establish more reliable findings by ensuring proper planning, implementation, and analysis of experiments.
Analyzing membrane integration of frdD requires specialized techniques due to its hydrophobic nature. The most effective methods include:
Biochemical fractionation approaches:
Differential centrifugation to isolate membrane fractions
Sucrose gradient ultracentrifugation for membrane subfractionation
Carbonate extraction (pH 11.5) to distinguish peripheral from integral proteins
Protease accessibility assays:
Controlled proteolysis of intact bacterial cells
Proteolysis of inside-out versus right-side-out membrane vesicles
Mass spectrometry analysis of protected fragments
Fluorescence-based techniques:
GFP fusion analysis for localization studies
Site-specific labeling with environment-sensitive fluorophores
Fluorescence quenching assays to determine topological organization
Electron microscopy approaches:
Immunogold labeling of thin sections
Freeze-fracture electron microscopy
Cryo-electron microscopy of membrane preparations
For quantitative assessment, combine multiple approaches and include appropriate controls (cytoplasmic and known membrane proteins) processed in parallel to validate fractionation quality.
Structural investigations of frdD can provide critical insights into Salmonella energy metabolism through:
Membrane complex organization:
High-resolution structures of complete fumarate reductase complexes
Analysis of subunit interactions between frdD and catalytic components
Identification of critical residues for complex stability
Electron transport mechanisms:
Elucidation of proton transfer pathways
Mapping of quinone binding sites and interactions
Structural changes associated with different redox states
Membrane adaption insights:
Lipid-protein interactions that modulate activity
Structural adaptations to different membrane environments
Conformational changes in response to environmental conditions
Future structural studies should employ innovative approaches like:
Cryo-electron microscopy in native-like lipid environments
Hydrogen-deuterium exchange mass spectrometry
Molecular dynamics simulations in model membranes
These investigations could reveal how metabolic adaptations enable Salmonella to thrive in diverse host environments, potentially identifying new targets for antimicrobial development.
The potential role of frdD in antimicrobial resistance involves several interconnected mechanisms:
Metabolic adaptation pathways:
Fumarate reductase activity can support bacterial survival under antibiotic stress
Alternative electron transport chains may maintain energy production when primary pathways are inhibited
Metabolic flexibility could enable persistence during antibiotic therapy
Membrane composition effects:
frdD-containing complexes may influence membrane properties and permeability
Changes in membrane organization could affect antibiotic penetration
Altered proton gradients might impact the efficacy of antibiotics dependent on membrane potential
Stress response coordination:
Metabolic shifts involving fumarate reductase may signal stress responses
Cross-talk between energy metabolism and resistance mechanisms
Potential role in bacterial persistence and tolerance
Future research should investigate how frdD expression patterns change in response to antibiotics and whether specific mutations in frdD correlate with increased resistance profiles. Combination therapies targeting both conventional mechanisms and metabolic adaptations might overcome resistance challenges.
Integrating frdD function into systems biology models of Salmonella metabolism requires multi-level approaches:
The resulting integrated models can predict how metabolic adaptations involving frdD contribute to Salmonella survival and pathogenesis, potentially identifying new therapeutic targets that disrupt essential metabolic functions.
Comparative analysis of frdD sequences across bacterial species reveals important evolutionary patterns:
Conservation and divergence patterns:
Core transmembrane domains show high conservation
Species-specific variations occur primarily in loop regions
Sequence conservation correlates with functional constraints
Phylogenetic relationships:
frdD phylogeny largely mirrors species phylogeny, suggesting vertical inheritance
Occasional horizontal gene transfer events in specific lineages
Co-evolution with other fumarate reductase subunits
Selective pressures:
Evidence of purifying selection on functional domains
Adaptive evolution in regions interfacing with other subunits
Host-specific adaptations in pathogenic species
Functional adaptation signatures:
Convergent evolution in unrelated anaerobic bacteria
Niche-specific amino acid substitutions
Correlation between sequence variations and ecological habitats
These evolutionary insights can inform the development of targeted intervention strategies that exploit species-specific features while minimizing cross-reactivity with host or beneficial microbiota.
The functional comparison of frdD between systemic and enteric pathovars of Salmonella reveals distinct adaptation patterns:
Expression regulation differences:
Systemic pathovars show differential regulation of frdD in response to host signals
Enteric variants maintain more constitutive expression patterns
Oxygen-dependent regulation varies between pathovars
Activity profile variations:
Systemic pathovars may exhibit optimized enzyme kinetics for intracellular environments
Enteric variants show adaptation to intestinal conditions
Temperature-dependent activity profiles reflect host adaptation
Structural adaptations:
Subtle sequence variations affect interaction with other complex components
Membrane integration efficiency may differ between pathovars
Post-translational modifications could vary based on lifestyle
This functional divergence aligns with broader patterns observed in Salmonella pathovars, where systemic and enteric strains show distinct virulence gene patterns . Understanding these differences can provide insights into the evolutionary trajectories that shape pathogen specialization and host adaptation.